Add like
Add dislike
Add to saved papers

Oxygen toxicity seizures: 20 years' experience from a single hyperbaric unit.

INTRODUCTION: Oxygen toxicity seizures (OTS) are a known complication of hyperbaric oxygen therapy (HBOT). The incidence of OTS has been variously reported and appears to be related to the duration and pressure of exposure in addition to individual susceptibility factors.

METHOD: All OTS occurring in patients undergoing HBOT during the first 20 years of operation of the Fremantle Hospital Hyperbaric Medicine Unit were reviewed.

RESULTS: During 41,273 HBOT in 3,737 patients, 25 OTS occurred; a rate of 0.06% (1/1,650 or 6 per 10,000) HBOT exposures. For the initial treatment of dysbarism with United States Navy Treatment Table 6, the rate was 0.56%. (4/714) and for the treatment of carbon monoxide (CO) poisoning was 0.18% overall but 0.49% for the first HBOT. There was an increasing OTS rate with increasing pressure with a statistically significant difference (P < 0.001) in OTS rate at 203 kPa or less versus > 203 kPa (OR 8.5, 95% confidence intervals (CI) 2.0 to 36.1), and for comparison of two commonly used pressures of 203 kPa versus 243 kPa (P = 0.028, OR 5.1, 95% CI 1.1 to 22.8), but not with first versus follow-up HBOT at 284 kPa for dysbarism (P = 0.061) nor CO (P = 0.142).

CONCLUSIONS: This study reports all OTS in a single hyperbaric unit over a 20-year period, the longest observational study period yet reported for OTS during HBOT for all indications. The incidence of OTS in this study compares favourably to previously reported rates, and shows an increasing OTS rate with increasing pressure.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app